Clinical Research Services

The combination of the MHRA Accreditation and the expert knowledge of conducting 500 Early Phase Studies ensure Richmond Pharmacology can provide you with a service that meets your needs.

Adaptive Phase I Studies

Rapid approval, flexible conduct, government agency accredited facility, experienced

TQT Studies

Unique all under one roof setting, world-class specialist clinic and core laboratory



Bridiging Studies

Longstanding European specialist provider of Japanese and Japanese Bridging studies since 2002

Patient Recruitment

Innovative record breaking specialist early phase patient recruitment



Latest news

DIA, Chicago 2017

23rd Jun 2017

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings

Read more ›

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28th Apr 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

Read more ›

New CRO unit facility welcomes first overnight patients

31st Mar 2017

Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.

Read more ›

American Society for Clinical Pharmacology and Therapeutics (ASCPT)

Mar 15th 2017 | Washington, D.C

Richmond Pharmacology is attending the American Society for Clinical Pharmacology and Therapeutics (ASCPT) event in Washington DC over the next few days.

View all events ›